Hangzhou Coco Healthcare Products Co.,Ltd. (SHE:301009)
China
· Delayed Price · Currency is CNY 15.30
-0.31 (-1.99%)
Jun 9, 2025, 2:45 PM CST
SHE:301009 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | 31.43 | 31.17 | 20.18 | -43.13 | 39.75 | 214.01 | Upgrade
|
| Depreciation & Amortization | 58.18 | 58.18 | 56.84 | 61.25 | 49.43 | 39.24 | Upgrade
|
| Other Amortization | 4.99 | 4.99 | 4.78 | 5.53 | 5.34 | 2.65 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.04 | 0.04 | 0.1 | -0.12 | -0.04 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.21 | 0.21 | 13.86 | 62.3 | 0.16 | 39.54 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.38 | 0.38 | 3.34 | -0.24 | -5.05 | -1.11 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.84 | 0.84 | -3.48 | 5.21 | -2.07 | - | Upgrade
|
| Other Operating Activities | 20.49 | 5.31 | 2.08 | -17.27 | 16.79 | 33.84 | Upgrade
|
| Change in Accounts Receivable | -44.84 | -44.84 | 55.6 | -30.95 | 114.13 | -101.19 | Upgrade
|
| Change in Inventory | -39.46 | -39.46 | 57.89 | -40.23 | -34.04 | 4.46 | Upgrade
|
| Change in Accounts Payable | 36.94 | 36.94 | 18.38 | -33.46 | -137.69 | 167.6 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 0.4 | Upgrade
|
| Operating Cash Flow | 67.88 | 52.44 | 227.7 | -37.2 | 50.53 | 395.86 | Upgrade
|
| Operating Cash Flow Growth | -69.25% | -76.97% | - | - | -87.24% | 77.26% | Upgrade
|
| Capital Expenditures | -55.41 | -75.35 | -66.01 | -116.4 | -240.45 | -220.71 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.16 | 4.44 | 0.69 | 0.61 | 0.47 | 0.12 | Upgrade
|
| Investment in Securities | -150 | -260 | -10.56 | - | 120 | -100.25 | Upgrade
|
| Other Investing Activities | 4.48 | 2.44 | 2.64 | 3.65 | 5.06 | 9.37 | Upgrade
|
| Investing Cash Flow | -201.1 | -328.47 | -73.25 | -112.14 | -114.92 | -311.47 | Upgrade
|
| Short-Term Debt Issued | - | 100.01 | 3.05 | - | 50 | 138.9 | Upgrade
|
| Total Debt Issued | 100.01 | 100.01 | 3.05 | - | 50 | 138.9 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -149.1 | -80.6 | Upgrade
|
| Long-Term Debt Repaid | - | -4.26 | -2.76 | -0.84 | -2.25 | - | Upgrade
|
| Total Debt Repaid | -4.26 | -4.26 | -2.76 | -0.84 | -151.35 | -80.6 | Upgrade
|
| Net Debt Issued (Repaid) | 95.74 | 95.74 | 0.3 | -0.84 | -101.35 | 58.3 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 761.55 | - | Upgrade
|
| Repurchase of Common Stock | -49.69 | -49.69 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -20.19 | -20.14 | - | -19.03 | -0.88 | -23.63 | Upgrade
|
| Other Financing Activities | 31.74 | 1.16 | 0.1 | -30 | 24.5 | -6.2 | Upgrade
|
| Financing Cash Flow | 57.61 | 27.07 | 0.4 | -49.87 | 683.82 | 28.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.15 | 6.21 | 2.14 | 4.24 | -2.65 | -11.65 | Upgrade
|
| Net Cash Flow | -71.47 | -242.75 | 156.99 | -194.97 | 616.78 | 101.21 | Upgrade
|
| Free Cash Flow | 12.47 | -22.91 | 161.69 | -153.6 | -189.92 | 175.15 | Upgrade
|
| Free Cash Flow Growth | -91.49% | - | - | - | - | 79.71% | Upgrade
|
| Free Cash Flow Margin | 1.16% | -2.12% | 14.95% | -12.95% | -16.01% | 10.71% | Upgrade
|
| Free Cash Flow Per Share | 0.05 | -0.09 | 0.56 | -0.57 | -0.81 | 0.86 | Upgrade
|
| Cash Income Tax Paid | - | -25.17 | -12.13 | -60.14 | -10.59 | -27.86 | Upgrade
|
| Levered Free Cash Flow | -10.87 | -34.57 | 134.51 | -266.81 | -285.95 | 105.74 | Upgrade
|
| Unlevered Free Cash Flow | -10.32 | -34.12 | 134.92 | -266.64 | -285.35 | 107.07 | Upgrade
|
| Change in Net Working Capital | 24.19 | 25.54 | -133.35 | 191.27 | 120.87 | -98.75 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.